Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for atypical odontalgia/persistent dentoalveolar pain
2019-003503-35Phase 2Completed
- Sponsor
- Region Östergötland
- Start
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Atypical Odontalgia (AO) comparing Botulinum toxin type A with Placebo (saline) (2 arms). Primary endpoint: Pain intensity (NRS). Started Dec 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Atypical Odontalgia (AO)
Beyond the preview
Go deeper on 2019-003503-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003503-35.